APA (7th ed.) Citation

Devarajan, S., Moon, I., Ho, M., Larson, N. B., Neavin, D. R., Moyer, A. M., . . . Reid, J. M. (2019). Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19. Drug metabolism and disposition, 47(4), 425. https://doi.org/10.1124/dmd.118.084269

Chicago Style (17th ed.) Citation

Devarajan, Sandhya, et al. "Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19." Drug Metabolism and Disposition 47, no. 4 (2019): 425. https://doi.org/10.1124/dmd.118.084269.

MLA (9th ed.) Citation

Devarajan, Sandhya, et al. "Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19." Drug Metabolism and Disposition, vol. 47, no. 4, 2019, p. 425, https://doi.org/10.1124/dmd.118.084269.